COPD Co-infection With Tuberculosis on Th17 Cell Differentiation
Conditions:   Tuberculosis Infection;   Chronic Obstructive Pulmonary Disease Intervention:   Other: No intervention Sponsors:   Peking University Third Hospital;   Beijing Geriatric Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 19, 2021 Category: Research Source Type: clinical trials

Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis
Conditions:   Disseminated Tuberculosis;   HIV Interventions:   Drug: Rifampin;   Drug: Prednisone;   Drug: Placebo;   Drug: Rifamp/Isoniazid/Pyrazinamide 120 Mg-50 Mg-300 Mg ORAL TABLET;   Drug: Levofloxacin Sponsor:   University of Cape Town Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2021 Category: Research Source Type: clinical trials

Testing New Strategies for Patients Hospitalised With HIV-associated Disseminated Tuberculosis
Conditions:   Disseminated Tuberculosis;   HIV Interventions:   Drug: Rifampin;   Drug: Levofloxacin;   Drug: Rifampicin, Pyrazinamide, Ethambutol and Isoniazid;   Drug: Prednisone;   Drug: Placebo Sponsor:   University of Cape Town Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2021 Category: Research Source Type: clinical trials

Airborne Preventive Measures to Reduce New TB Infections in Household Contacts
Conditions:   Tuberculosis, Pulmonary;   Household Contacts;   Tuberculosis Intervention:   Combination Product: Respiratory bundle Sponsors:   Pontificia Universidad Catolica de Chile;   Fondo Nacional de Desarrollo Científico y Tecnológico, Chile;   Agencia Nacional de Investigación y Desarrollo, ANID Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 24, 2021 Category: Research Source Type: clinical trials

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Conditions:   COVID-19 Respiratory Infection;   Pulmonary Tuberculoses Intervention:   Sponsor:   Tuberculosis Research Centre, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Conditions:   Tuberculosis;   Pulmonary Tuberculosis;   HIV Coinfection Interventions:   Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide;   Drug: Metformin hydrochoride Sponsors:   University of Massachusetts, Worcester;   National Institute of Allergy and Infectious Diseases (NIAID);   Aurum Institute;   Singapore Immunology Network;   University of Cape Town Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Conditions:   COVID-19 Respiratory Infection;   Pulmonary Tuberculoses Intervention:   Sponsor:   Tuberculosis Research Centre, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Conditions:   Tuberculosis;   Pulmonary Tuberculosis;   HIV Coinfection Interventions:   Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide;   Drug: Metformin hydrochoride Sponsors:   University of Massachusetts, Worcester;   National Institute of Allergy and Infectious Diseases (NIAID);   Aurum Institute;   Singapore Immunology Network;   University of Cape Town Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Conditions:   COVID-19 Respiratory Infection;   Pulmonary Tuberculoses Intervention:   Sponsor:   Tuberculosis Research Centre, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Conditions:   Tuberculosis;   Pulmonary Tuberculosis;   HIV Coinfection Interventions:   Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide;   Drug: Metformin hydrochoride Sponsors:   University of Massachusetts, Worcester;   National Institute of Allergy and Infectious Diseases (NIAID);   Aurum Institute;   Singapore Immunology Network;   University of Cape Town Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Conditions:   COVID-19 Respiratory Infection;   Pulmonary Tuberculoses Intervention:   Sponsor:   Tuberculosis Research Centre, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Conditions:   Tuberculosis;   Pulmonary Tuberculosis;   HIV Coinfection Interventions:   Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide;   Drug: Metformin hydrochoride Sponsors:   University of Massachusetts, Worcester;   National Institute of Allergy and Infectious Diseases (NIAID);   Aurum Institute;   Singapore Immunology Network;   University of Cape Town Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Conditions:   COVID-19 Respiratory Infection;   Pulmonary Tuberculoses Intervention:   Sponsor:   Tuberculosis Research Centre, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Conditions:   Tuberculosis;   Pulmonary Tuberculosis;   HIV Coinfection Interventions:   Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide;   Drug: Metformin hydrochoride Sponsors:   University of Massachusetts, Worcester;   National Institute of Allergy and Infectious Diseases (NIAID);   Aurum Institute;   Singapore Immunology Network;   University of Cape Town Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Conditions:   COVID-19 Respiratory Infection;   Pulmonary Tuberculoses Intervention:   Sponsor:   Tuberculosis Research Centre, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Conditions:   Tuberculosis;   Pulmonary Tuberculosis;   HIV Coinfection Interventions:   Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide;   Drug: Metformin hydrochoride Sponsors:   University of Massachusetts, Worcester;   National Institute of Allergy and Infectious Diseases (NIAID);   Aurum Institute;   Singapore Immunology Network;   University of Cape Town Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Conditions:   COVID-19 Respiratory Infection;   Pulmonary Tuberculoses Intervention:   Sponsor:   Tuberculosis Research Centre, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
Conditions:   Tuberculosis;   Pulmonary Tuberculosis;   HIV Coinfection Interventions:   Drug: Isoniazid;   Drug: Rifampicin;   Drug: Ethambutol;   Drug: Pyrazinamide;   Drug: Metformin hydrochoride Sponsors:   University of Massachusetts, Worcester;   National Institute of Allergy and Infectious Diseases (NIAID);   Aurum Institute;   Singapore Immunology Network;   University of Cape Town Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis
Conditions:   COVID-19 Respiratory Infection;   Pulmonary Tuberculoses Intervention:   Sponsor:   Tuberculosis Research Centre, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 18, 2021 Category: Research Source Type: clinical trials